Improvement in severe insulin resistance with frequent injections of lispro insulin

Journal of the National Medical Association

Volumn 91, Issue 7, 1999, Pages 410-X

  Raine III, Charles H ^a,b   Krzyston, Mark J ^a   Amr, Mostafa ^a   Hydrick, Lyn ^a  

^a Diabetes Control Center   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; INSULIN LISPRO;

ARTICLE; CASE REPORT; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; OBESITY;

EID: 0033155125     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fredrickson L, ed. The Insulin Pump Therapy Book. Sylmar, CA: MiniMed Technologies; 1995.
2. Humalog [package insert]. Indianapolis, IN: Eli Lily Co.
3. Ostrega D, Polonsky K, Nagi G. Measurement of proinsulin and intermediates: validation of immunoassay methods by high-performance liquid chromatography. Diabetes. 1995;44:437-440.
4. Kippen AD, Cerini F, Vadas L, et al. Development of an isotope dilution assay for precise determination of insulin, C-peptide, and proinsulin levels in non-diabetic and type II diabetic individuals with comparison to immunoassay. J Biol. Chem. 1997;272:12513-12522.
5. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia. 1987;30:698-702.
6. Yoshioka N, Kuzuya T, Matsuda A, Iwamoto Y. Effects of dietary treatment on serum insulin and proinsulin response in newly diagnosed NIDDM. Diabetes. 1989;38:262-266.
7. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type 2 diabetes in the offspring of diabetic parents. Ann Intern Med. 1990;113:909-915.
8. Yki-Jarvinen H. Glucose toxicity. Endocr Rev. 1992;13:415-431.
9. Polonsky KS. The beta-cell in diabetes: from molecular genetics to clinical research. Lily Lecture 1994. Diabetes. 1995; 44:705-717.
10. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75:473-486.
11. Ling Z, Kiekens R, Maher T, et al. Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta cells. Diabetes. 1996;45:1774-1782.
12. Ilkova H, Glaser B, Tunckale A, Bagriacik N, Cerasi E. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care. 1997;20:1353-1356.
13. Anello M, Rabuazzo A, Degano C, et al. Fast reversibility of glucose-induced desensitization in rat pancreatic islets: evidence for an involvement of ionic fluxes. Diabetes. 1996;45:502-506.
14. Howey DC, Bowsher RR, Brunelle R, Woodworm JR. [Lys(B28), Pro(B29)]-human insulin; a rapidly absorbed analogue of human insulin. Diabetes. 1994;43:396-402.